Using COVID as the catalyst, enhancing organizational resilience with a simplified business continuity framework and program to enable an integrated one Roche approach to respond to business disruption. The long term outcomes include a) Enhancement and embedment of Organizational Resilience into Product Development Culture for a pharma organization, and b) Understanding, assessing and capturing new and emerging threats & vulnerabilities.
One consolidated and simplified process with greater clarity to the interdependencies and alignment across continuity process for product development prioritization and efficiencies when responding to a serious business disruption. Let's go through the outcomes together, simplified framework, more robust communication channels, formalization of cross functional / cross business unit information sharing and End to End Process planning.